SUBSCRIBE
SUBSCRIBE
News   Drug Development

BioInvent Interim Report 1 January – 30 June 2016

July 26, 2016 | 
1 min read

LUND, Sweden--(BUSINESS WIRE)--Regulatory News:

BioInvent (STO:BINV)

Second quarter 2016, April - June

· Net sales for April-June 2016 amounted to SEK 10 (3.7) million.

Clinical research Phase II Earnings Europe
MORE ON THIS TOPIC
A human hand showing dollar golden coins in the jar with a colored background. Collage Art of finance
Manufacturing
J&J, Legend Pump $150M Into Manufacturing in Bid to Double Carvykti Production
March 13, 2025
 · 
2 min read
 · 
Tristan Manalac
Businessman holding a dart aiming at the target - business targeting, aiming, focus concept. Art collage.
Infectious disease
Gilead, GSK-ViiV Move Ahead With Long-Acting HIV Options Following Early-Stage Readouts
March 12, 2025
 · 
2 min read
 · 
Tristan Manalac
Pictured: Entrance to Pfizer's office in Belgium
Breast cancer
Pfizer, Arvinas Post Mixed Late-Stage Breast Cancer Data for Closely Watched PROTAC Drug
March 11, 2025
 · 
2 min read
 · 
Tristan Manalac
Dollar banknote cut into pieces on a yellow background
Gene therapy
Roche Absorbs $2.4B Impairment in Overhaul of Spark Gene Therapy Unit
March 11, 2025
 · 
2 min read
 · 
Tristan Manalac